1
|
Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa.
|
Ann Oncol
|
2010
|
1.45
|
2
|
Gene expression profiling of human colon cancer cells following inhibition of signal transduction by 17-allylamino-17-demethoxygeldanamycin, an inhibitor of the hsp90 molecular chaperone.
|
Oncogene
|
2000
|
1.34
|
3
|
Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.
|
Genes Chromosomes Cancer
|
1995
|
1.05
|
4
|
Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs.
|
Med Oncol
|
2011
|
0.96
|
5
|
Prognosis and predictive value of KIT exon 11 deletion in GISTs.
|
Br J Cancer
|
2009
|
0.92
|
6
|
Role of thymus-eicosanoids in the immune response.
|
Prostaglandins Leukot Essent Fatty Acids
|
1992
|
0.87
|
7
|
Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
|
Br J Cancer
|
1999
|
0.75
|
8
|
Competitive polymerase chain reaction to quantify tumor cells in peripheral blood of patients with T(14;18)-bearing follicular non-Hodgkin's lymphoma: an exploratory study in 8 patients.
|
Int J Cancer
|
1999
|
0.75
|